Form 4 for ILMN ILLUMINA, INC.
Accepted 2023-02-23 00:00:00 ET · period of report 2023-02-21 · accession 0001127602-23-006823 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-23 | 2023-02-21 | ILMN | Febbo Phillip G. | SVP Chief Medical Off | F - Tax | $202.84 | -1,245 | 7,230 | -15% | -$252.5K |
| D | 2023-02-23 | 2023-02-21 | ILMN | Febbo Phillip G. | SVP Chief Medical Off | M - OptEx | $0.00 | +3,522 | 8,475 | +71% | $0 |
| D | 2023-02-23 | 2023-02-21 | ILMN | Febbo Phillip G. | SVP Chief Medical Off | M - OptEx | $0.00 | -3,522 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | F | D | 1,245 | $202.84 | 7,230 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-21 | M | A | 3,522 | $0.00 | 8,475 | D | — | — | (F1) Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. |
| 3 | Derivative | Performance Shares | 2023-02-21 | M | D | 3,522 | $0.00 | 0 | D | — · — to 2023-01-01 | 3,522 Common Stock | (F1) Represents shares of stock awarded as a result of the Company achieving at least 94% of the applicable performance criteria pursuant to the reporting person's grant of performance share units on February 5, 2020. |